Phyllodes Tumour of the Breast: Clinicopathological Analysis of Recurrent vs. Non-recurrent Cases
Article Outline
Background
The aim of this study was to present our experience of dealing with patients with phyllodes tumours (PT) and to correlate the risk of local recurrence with different clinicopathological factors.
Materials and Methods
This was a retrospective study of 25 women with PT, who were managed at our centre between 1991 and 2005. All the available clinical, operative and histological details were retrieved. The median follow-up period was 4 years (range, 1–9 years). Various clinicopathological features were compared between patients who suffered from recurrent tumours to those not experiencing any recurrence.
Results
The mean age of the patients was 45 ± 7 years and the mean duration of symptoms was 30 ± 10 months. The mean tumour diameter was 10.5 ± 5 cm. Preoperative diagnosis with fine needle aspiration cytology could be made in 72% of cases. Overall, 39 surgical procedures were performed (14 of which were performed for recurrences). The histology report was benign, borderline and malignant PT in 28%, 20% and 52% of cases respectively. Recurrent tumours were observed in 36% of patients and 16% experienced more than one recurrence. Two patients with malignant PT developed metastases in the follow-up period, and one of them died. Except for the extent of primary surgery, there were no significant differences in other clinicopathological factors between the recurrent and non-recurrent groups. Patients who had wide local excision (WLE) and procedures of greater magnitudes as primary procedures did not experience recurrence (p = 0.008). However, when WLE was performed for recurrent tumours, 50% of patients suffered from recurrence.
Conclusion
WLE seems to be the initial procedure of choice for all PTs, and mastectomy for recurrent tumours. Further studies are needed to define the role of adjuvant therapies.
Key Words: breast cancer , phyllodes tumours , tumour recurrence
No full text is available. To read the body of this article, please view the PDF online.
References
- The treatment and prognosis of patients with phyloides tumour of the breast: an analysis of 170 cases . Cancer . 1996;77:910–916
- Phyllodes tumours: a clinicopathological review of 30 cases . Aust N Z J Surg . 1992;62:628–633
- . Recurrent cystosarcoma phyllodes: a clinicopathologic study of 32 cases . Cancer . 1976;38:1402–1406
- . Sarcoma of the breast . In: Bennington J editors. Problems in Breast Pathology . Philadelphia: WB Saunders Co.; 1979;p. 355–359
- Surgical treatment of phyllodes tumours of the breast . Cancer . 1989;63:2532–2536
- Cystosarcoma phyllodes of the breast: a new therapeutic proposal . Am Surg . 1982;48:157–166
- Phyllodes tumour of the breast. Personal contribution of 21 cases . G Chir . 2000;21:453–456
- . Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre . Ann R Coll Surg Engl . 1995;77:181–184
- Phyllodes tumour: an update of 40 cases . Ann Acad Med Singapore . 1998;27:200–203
- Optimising preoperative diagnosis in phyllodes tumour of the breast . J Clin Pathol . 2006;59:454–459
- Phyllodes tumours . Am J Surg . 1993;165:376–379
- . Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13-year experience . J R Coll Surg Edinb . 2001;46:198–201
- . Estradiol binding protein in cystosarcoma phyllodes of the breast . Eur J Cancer . 1980;16:591–593
- Cystosarcoma phyllodes: effective therapy with cisplatin and etoposide chemotherapy . Cancer . 1989;63:2088–2092
- Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes . Cancer . 1992;69:2271–2275
PII: S1015-9584(09)60398-5
doi:10.1016/S1015-9584(09)60398-5
© 2009 Asian Surgical Association. Published by Elsevier Inc. All rights reserved.
